Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series

Mary Tschann, Alison Edelman, Jeffrey Jensen, Paula Bednarek, Bliss Kaneshiro

Research output: Contribution to journalArticle

Abstract

Objective: Describe blood loss with surgical abortion ≥16. weeks of gestation in anticoagulated patients. Study design: Clinicians involved in a professional listserv (2011-2013) reported cases of abortion ≥16. weeks of gestation in anticoagulated women. Results: All 7 patients were using or had recently discontinued low molecular weight heparin (LMWH). One patient was reported to have greater than anticipated blood loss for gestational age. No patients required transfusion and no complications were reported. Conclusions: Our limited case series suggests D&E may not always be contraindicated in women with recent or current LMWH use.

Original languageEnglish (US)
JournalContraception
DOIs
StateAccepted/In press - 2017

Keywords

  • Abortion
  • Anticoagulant
  • Blood loss
  • Dilation
  • Evacuation

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series'. Together they form a unique fingerprint.

  • Cite this